BMS is the last major AIDS drug manufacturer to announce additional special discounts for cash-strapped ADAPs, despite the fact that the crisis is now so severe, 2718 individuals in thirteen claims are on waiting lists to receive lifesaving AIDS medications through the scheduled system. BMS provides been the mark of a sustained advocacy advertising campaign led by AHF over its prices of its key AIDS drug Reyataz for ADAPs. AHF attempts have got included: banning BMS product sales representatives from AHF Health care Centers, a Shame on BMS postcard and ad campaign, an e-advocacy campaign that generated a huge selection of e-letters from AIDS advocates from all areas of the country to BMS CEO Andreotti and several open public protests.In the primary evaluation of HIV transmissions determined by laboratory assessment to have occurred within the couple and not acquired from another partner, there were 41 attacks in the acyclovir arm and 43 in the placebo arm – not really a significant difference. Of the companions who were infected with HIV, 68 percent were women. Acyclovir suppressive treatment do display significant reductions in the regularity of genital ulcers and the common amount of HIV in the blood , compared to the placebo arm. Related StoriesRutgers College of Nursing takes business lead in $6 million nationwide effort to prevent brand-new HIV infectionsStudy evaluates efficiency of antiretroviral treatment in HIV-infected childrenNew study finds high prevalence of HIV among pregnant refugee ladies in Ontario’As is often the case with huge efficacy trials, you learn to expect surprises,’ said Dr.